Hyperion Partners’s Johnson & Johnson JNJ Stock Holding History

Hyperion Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$4.38M	Sell	27,024 -95	-0.4%	-$15.1K	2.79%	12
2024 Q2	$3.96M	Sell	27,119 -45	-0.2%	-$6.69K	2.83%	12
2024 Q1	$4.3M	Sell	27,164 -247	-0.9%	-$39.3K	3.15%	12
2023 Q4	$4.3M	Sell	27,411 -179	-0.6%	-$27.4K	3.4%	11
2023 Q3	$4.3M	Buy	27,590 +3	+0%	+$495	3.71%	11
2023 Q2	$4.57M	Sell	27,587 -29	-0.1%	-$4.68K	3.85%	10
2023 Q1	$4.28M	Buy	27,616 +136	+0.5%	+$22K	3.85%	10
2022 Q4	$4.85M	Buy	+27,480	New	+$4.74M	4.64%	9

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hyperion Partners's JNJ Position: Q3 2024 in Review

Hyperion Partners reduced its Johnson & Johnson (JNJ) stake by 0.35% in Q3 2024, selling an estimated $15.1K and leaving 27,024 shares worth $4.38M. The position accounts for 2.79% of the portfolio, ranked #12.

Hyperion Partners first reported a position in JNJ in Q4 2022 and has held it in 8 quarters since. The position peaked at $4.85M in Q4 2022. 3,889 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

Hyperion Partners held 27,024 shares of Johnson & Johnson worth $4.38M as of Q3 2024.
Hyperion Partners sold 95 Johnson & Johnson shares in Q3 2024, an estimated $15.1K.
Johnson & Johnson made up 2.79% of Hyperion Partners's portfolio in Q3 2024, its #12 holding.
Hyperion Partners first reported a position in Johnson & Johnson in Q4 2022 and has held it in 8 quarters since.
Hyperion Partners's Johnson & Johnson position peaked at $4.85M in Q4 2022.
3,889 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Hyperion Partners's 13F filing for Q3 2024, filed 9 Oct 2024.